Article info

Download PDFPDF

Telmisartan and Insulin Resistance in HIV (TAILoR): protocol for a dose-ranging phase II randomised open-labelled trial of telmisartan as a strategy for the reduction of insulin resistance in HIV-positive individuals on combination antiretroviral therapy

Authors

  1. Correspondence to Professor Munir Pirmohamed; munirp{at}liv.ac.uk
View Full Text

Citation

Pushpakom SP, Taylor C, Kolamunnage-Dona R, et al
Telmisartan and Insulin Resistance in HIV (TAILoR): protocol for a dose-ranging phase II randomised open-labelled trial of telmisartan as a strategy for the reduction of insulin resistance in HIV-positive individuals on combination antiretroviral therapy

Publication history

  • Received July 29, 2015
  • Revised August 17, 2015
  • Accepted August 28, 2015
  • First published October 15, 2015.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.